Read more
The series
Stem Cell Innovation in Health and Disease is a timely and fascinating collection of information and new discoveries and provides a contemporary snapshot album from the fast-moving field of regenerative medicine and stem cell therapeutics.
The Nervous System, Volume 5 addresses the recent data accumulated on the potential applications of stem cells to treat diseases and disorders of the nervous system. This volume will highlight the recent development of cutting edge in vitro and in vivo research tools and approaches, including human and murine organoid cultures, genetic editing in vitro and in vivo, human iPSC models of disease, haploid cells for genetic as well as compound screening paradigms, genetically engineered mice, and stem cell transplantation to treat nervous system disorders and diseases. The volume is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine and organ transplantation; and is contributed by world-renowned authors in the field.
List of contents
1. Stem Cell-based Organoid Culture System
2. Applying Innovative Genome Editing Technologies in Stem Cell Engineering, and Neurological Disorders and Diseases
3. Role of Genetically Engineered Animal Models in Investigating Neurogenic Diseases and Disorders
4. Stem Cell Therapeutics in Neurological Disorder: Classification, Mechanism and Clinical Application
5. Emerging trends in stem cell-based treatments for neurodegenerative diseases
6. Derivation and Application of Haploid Neural Stem Cells in CNS Disorders and Diseases
7. Mesenchymal Stem Cell Related Therapies for Neurological Diseases and Disorders
8. The Gold Standard iPSCs and iPSC-derived Neural Cells in Modeling Neurological Diseases
9. Conclusion and Future Direction
About the author
Professor Dr. Mayeen Uddin Khandaker obtained B.Sc. (Hons.) and M.Sc. in Physics from Chittagong University, Bangladesh. During his PhD study in Korea, he performed research work on measurements and evaluation of nuclear data for the production of medically and technologically important radionuclides for practical applications. Prof. Khandaker started his career as a lecturer of Physics in the International Islamic University Chittagong, Bangladesh. He also served as an Assistant Professor of Physics in the American International University-Bangladesh, an Associate Professor of Physics in the University of Malaya, Malaysia, and currently as a Professor of Biomedical Physics in Sunway University, Malaysia. Professor Khandaker serves as an associate editor for the journal of Radiation Physics and Chemistry.Dr. Mohsin Kazi is Professor at Pharmaceutics department, College of Pharmacy, King Saud University, Saudi Arabia. Prior to joining King Saud University, Dr. Mohsin was working as post-doctoral research fellow in Monash University, Australia. Previously, he had worked in Abbott Laboratories, Chicago, USA. Dr. Mohsin obtained B. Pharm (HONS) and PhD in Pharmacy from Monash University, and MBA from Victoria University, Australia. His research expertise include development of oral lipid-based nano-formulation systems & drug absorption of challenging poorly soluble drugs, conversion of liquid into solid dosage form, and immediate release formulation design. He has authored more than 100 scientific publications and delivered many presentations in international pharmaceutical conferences. He has research collaboration with various universities such as California Health Science Institute, Coppin state university, USA, Monash Institute of Pharmaceutical Science, Australia, North South University, and Dhaka university, Bangladesh. He has numerous funded research project approved by KACST and European Union. Dr. Mohsin is currently leading a lipid research group and advisor to several PhD & M.Sc. students. Dr Mohsin is the current academic visitor of Monash Institute of Pharmaceutical Science, Monash University in Australia
